Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Conditions: Hepatoblastoma; Hepatocellular Carcinoma; Wilms Tumor; Malignant Rhabdoid Tumor; Yolk Sac Tumor; Rhabdomyosarcoma; Liposarcoma; Embryonal Sarcoma of Liver Interventions: Genetic: 21.15.GPC3-CAR T cells Sponsors: Baylor College of Medicine; Center for Cell and Gene Therapy, Baylor College of Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Baylor College of Medicine | Cancer & Oncology | Carcinoma | Embryonal Carcinoma | Gene Therapy | Genetics | Hepatoblastoma | Hepatocellular Carcinoma | Immunotherapy | Liposarcoma | Liver | Liver Cancer | Research | Rhabdomyosarcoma | Sarcomas | Urology & Nephrology | Wilm's Tumor | Yolk Sac Tumor